This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ventas, Inc. is a healthcare real estate investment trust (REIT) that is primarily engaged in acquisition and ownership of senior housing, R&I and healthcare properties, and leasing them to unaffiliated tenants or operating them through independent third-party managers. Ventas offers MOB management, leasing, marketing, facility development and advisory services to well-rated hospitals and health systems throughout the United States through its ownership interest in PMB Real Estate Services LLC and the company’s subsidiary, Lillibridge Healthcare Services, Inc. It also makes secured and non-mortgage loans and other investments relating to senior housing and healthcare properties or operators.
Here's Why Investors Should Retain Ventas (VTR) Stock for Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.
Ventas' (VTR) Q3 FFO Beat on SHOP NOI Growth, '23 View Revised
by Zacks Equity Research
Ventas's (VTR) Q3 earnings outshine estimates on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance across the portfolio. The company has revised its 2023 outlook.
Compared to Estimates, Ventas (VTR) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Is a Beat in the Offing for Ventas (VTR) in Q3 Earnings?
by Zacks Equity Research
Favorable senior housing operating portfolio operating trends, robust demand for life-science real-estate assets and accretive investments are likely to have benefited Ventas' (VTR) Q3 earnings.
Regency Centers (REG) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Healthy demand for Regency Centers' (REG) shopping centers and gains from accretive acquisitions are likely to have benefited its Q3 earnings. However, higher interest rates might have ailed.
Factors to Impact Innovative Industrial's (IIPR) Q3 Earnings
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q3 performance, though high expenses might have played a spoilsport.
Key Factors to Impact Boston Properties' (BXP) Q3 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q3 earnings. However, higher interest expenses might have hurt it.
What's in the Offing for Host Hotels (HST) in Q3 Earnings?
by Zacks Equity Research
Host Hotels' (HST) Q3 earnings are likely to have benefited from the continued strength in group travel and business transient demand. However, higher interest expenses might have hurt it.
Is a Beat in the Cards for Welltower (WELL) in Q3 Earnings?
by Zacks Equity Research
Welltower's (WELL) Q3 earnings are likely to have benefited from the rise in senior citizen's healthcare expenditure and accretive capital deployment activity.
Is a Beat in Store for Healthpeak (PEAK) in Q3 Earnings?
by Zacks Equity Research
Robust demand for Healthpeak's (PEAK) lab assets and a rise in senior citizen's healthcare expenditure are expected to have benefited its Q3 earnings.
Getty Realty (GTY) Tops Q3 FFO and Revenue Estimates
by Zacks Equity Research
Getty Realty (GTY) delivered FFO and revenue surprises of 1.79% and 9.33%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investors Should Retain Ventas (VTR) Stock for Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.
Ventas (VTR) Partners With Operators for Senior Housing Growth
by Zacks Equity Research
Ventas (VTR) teams up with expert operators to enhance the performance of 26 independent living communities.
Medical Properties (MPW) Beats on Q2 FFO, Narrows '23 View
by Zacks Equity Research
Medical Properties' (MPW) Q2 results reflect lower-than-anticipated revenues. Higher interest expenses during the quarter act as a dampener. The company narrows its 2023 outlook.
Digital Realty (DLR) Unveils Solution to Meet Data Challenges
by Zacks Equity Research
Digital Realty (DLR) unveils high-density colocation service across its global data center platform, PlatformDIGITAL, to help businesses address data and AI growth challenges, and optimize performance.
Four Corners (FCPT) Buys $1.6M Iowa Property, Bolsters Growth
by Zacks Equity Research
Four Corners (FCPT) bolsters its external growth strategy with its recent acquisition of a Jiffy Lube property in Iowa for $1.6 million.
Four Corners (FCPT) Boosts Portfolio With Strategic Buyouts
by Zacks Equity Research
To boost its portfolio with real estate leased to strong credit operators, Four Corners (FCPT) announces the acquisition of a dual-tenant Aspen Dental and WellNow Urgent Care property.
Ventas' (VTR) Q2 FFO Beats, SHOP NOI Up, '23 View Revised
by Zacks Equity Research
Ventas (VTR) posts solid Q2 results on better-than-anticipated revenues. The same-store cash NOI rises year over year on strong performance across the portfolio. The company revises its 2023 outlook.
Compared to Estimates, Ventas (VTR) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ventas (VTR) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 1.35% and 2.46%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Robinhood Markets, Inc. (HOOD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Robinhood Markets, Inc. (HOOD) delivered earnings and revenue surprises of 250% and 2.31%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Extra Space Storage (EXR) in Q2 Earnings?
by Zacks Equity Research
Extra Space Storage's (EXR) Q2 results are likely to reflect gains from high brand value and its solid presence in key cities, while an anticipated rise in vacating volumes is likely to have led to pricing pressure.
What's in the Offing for Regency Centers (REG) in Q2 Earnings?
by Zacks Equity Research
Healthy demand for Regency Centers' (REG) shopping centers, a solid tenant base and gains from accretive acquisitions are likely to have benefited the company's Q2 earnings.
Is a Beat in Store for Ventas (VTR) This Earnings Season?
by Zacks Equity Research
Favorable operating trends of the senior housing operating portfolio and robust demand for its life-science real-estate assets are likely to have benefited Ventas' (VTR) Q2 earnings.
What's in the Cards for Iron Mountain (IRM) in Q2 Earnings?
by Zacks Equity Research
Resilient storage and record management businesses and data center business expansion are likely to have aided Iron Mountain's (IRM) Q2 earnings. Adverse foreign exchange movements might have ailed.